Keyword: NewLink Genetics

Research

NewLink grabs up to $76M in Ebola vax assistance

On the heels of crushing Phase III results for its pancreatic cancer candidate, NewLink Genetics has won a lifeline from the U.S. government. The biotech nabbed up to $76 million in BARDA funding to advance its Merck-licensed Ebola vaccine.